Timothy M. Uyeki

Q: What Schools Are Affiliated With Timothy M. Uyeki

Timothy M. Uyeki is affiliated with the following schools: University of California, Berkeley, California Institute of Technology, Stanford University

Timothy M. Uyeki's AcademicInfluence.com Rankings

Timothy M. Uyeki

Medical

#2273

World Rank

#2684

Historical Rank

Public Health

#338

World Rank

#350

Historical Rank

Epidemiology

#395

World Rank

#414

Historical Rank

medical Degrees

Timothy M. Uyeki

Law

#2428

World Rank

#3018

Historical Rank

Common Law

#95

World Rank

#104

Historical Rank

law Degrees

Download Badge

Medical
Law

Timothy M. Uyeki's Degrees

PhD Epidemiology University of California, Berkeley
Doctorate Internal Medicine Stanford University

Why Is Timothy M. Uyeki Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Timothy M. Uyeki's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

First Case of 2019 Novel Coronavirus in the United States (2020) (5157)
Emergence of a novel swine-origin influenza A (H1N1) virus in humans. (2009) (2657)
Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans (2009) (2458)
Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). (2006) (2456)
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. (2009) (1475)
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. (2009) (1047)
Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. (2010) (994)
A minimal common outcome measure set for COVID-19 clinical research (2020) (939)
Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). (2011) (780)
Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. (2009) (666)
Influenza-associated deaths among children in the United States, 2003-2004. (2005) (637)
Epidemiology of human infections with avian influenza A(H7N9) virus in China. (2014) (618)
Update on avian influenza A (H5N1) virus infection in humans. (2008) (593)
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. (2010) (544)
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (2002) (539)
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. (2014) (531)
Guidelines for preventing opportunistic infections among HIV-infected persons - 2002 (2002) (474)
Severe Community-acquired Pneumonia Due to Staphylococcus aureus, 2003–04 Influenza Season (2006) (398)
2009 Pandemic Influenza A (H1N1) (2010) (387)
Evolution of H5N1 Avian Influenza Viruses in Asia (2005) (383)
Characteristics and Clinical Outcomes of Adult Patients Hospitalized with COVID-19 — Georgia, March 2020 (2020) (370)
Persistence of Ebola Virus in Ocular Fluid during Convalescence. (2015) (366)
Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014 (2016) (352)
Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. (2009) (349)
Three Indonesian clusters of H5N1 virus infection in 2005. (2006) (347)
Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. (2009) (347)
Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak — United States, December 31, 2019–February 4, 2020 (2020) (337)
Clinical care of two patients with Ebola virus disease in the United States. (2014) (324)
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. (2008) (317)
Effects of influenza on pregnant women and infants. (2012) (313)
Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus - United States, 2009. (2009) (300)
Facemasks and Hand Hygiene to Prevent Influenza Transmission in Households (2009) (300)
Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States* (2012) (298)
Preliminary Report: Epidemiology of the Avian Influenza A (H7N9) Outbreak in China (2013) (292)
Clinical Management of Ebola Virus Disease in the United States and Europe. (2016) (290)
Viral Shedding and Clinical Illness in Naturally Acquired Influenza Virus Infections (2010) (288)
Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China (2008) (287)
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. (2018) (287)
Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States (2020) (282)
Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. (2004) (280)
Maternal influenza vaccination and effect on influenza virus infection in young infants. (2011) (275)
Aerosol transmission is an important mode of influenza A virus spread (2013) (259)
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. (2019) (248)
Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States (2020) (245)
Isolation and Characterization of Avian Influenza Viruses, Including Highly Pathogenic H5N1, from Poultry in Live Bird Markets in Hanoi, Vietnam, in 2001 (2005) (236)
Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series. (2017) (232)
Low sensitivity of rapid diagnostic test for influenza. (2009) (231)
Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza (2003) (225)
Global concerns regarding novel influenza A (H7N9) virus infections. (2013) (219)
Critically Ill Children During the 2009–2010 Influenza Pandemic in the United States (2011) (218)
Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. (2012) (213)
Influenza-Associated Pediatric Mortality in the United States: Increase of Staphylococcus aureus Coinfection (2008) (213)
Neurologic complications associated with novel influenza A (H1N1) virus infection in children - Dallas, Texas, May 2009. (2009) (208)
Seasonality, timing, and climate drivers of influenza activity worldwide. (2012) (207)
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. (2012) (195)
Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection - United States, April-August 2009. (2009) (194)
WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus (2006) (186)
Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. (2011) (184)
The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States. (2015) (179)
Antivirals for Treatment of Influenza (2012) (173)
Preliminary Findings of a Randomized Trial of Non-Pharmaceutical Interventions to Prevent Influenza Transmission in Households (2008) (170)
Neurologic Complications Associated With Influenza A in Children During the 2003–2004 Influenza Season in Houston, Texas (2004) (163)
Findings from a household randomized controlled trial of hand washing and face masks to reduce influenza transmission in Bangkok, Thailand (2011) (159)
Incidence, Seasonality and Mortality Associated with Influenza Pneumonia in Thailand: 2005–2008 (2009) (155)
Clinical Characteristics of 26 Human Cases of Highly Pathogenic Avian Influenza A (H5N1) Virus Infection in China (2008) (153)
Outbreak of Variant Influenza A(H3N2) Virus in the United States (2013) (150)
Epidemiology of cases of H5N1 virus infection in Indonesia, July 2005-June 2006. (2007) (149)
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. (2007) (148)
Multistate Surveillance for Laboratory-Confirmed, Influenza-Associated Hospitalizations in Children: 2003–2004 (2006) (145)
Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. (2009) (144)
Human Case of Swine Influenza A (H1N1) Triple Reassortant Virus Infection, Wisconsin (2008) (142)
Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season. (2006) (139)
First 12 patients with coronavirus disease 2019 (COVID-19) in the United States (2020) (139)
Viral Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Influenza Virus Infections in the Community (2016) (138)
Novel influenza A (H1N1) virus infections in three pregnant women - United States, April-May 2009. (2009) (136)
Update: novel influenza A (H1N1) virus infection - Mexico, March-May, 2009. (2009) (136)
Detecting Human-to-Human Transmission of Avian Influenza A (H5N1) (2007) (134)
Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection. (2012) (131)
Transparent Development of the WHO Rapid Advice Guidelines (2007) (131)
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). (2004) (130)
Risk factors for human illness with avian influenza A (H5N1) virus infection in China. (2009) (128)
Severity of 2009 Pandemic Influenza A (H1N1) Virus Infection in Pregnant Women (2010) (127)
Health Benefits, Risks, and Cost-Effectiveness of Influenza Vaccination of Children (2006) (126)
Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS) (2019) (126)
Influenza virus-related critical illness: prevention, diagnosis, treatment (2019) (120)
Evidence-based guidelines for supportive care of patients with Ebola virus disease (2017) (114)
Family Clustering of Avian Influenza A (H5N1) (2005) (113)
Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1 (2014) (111)
H1N1 Encephalitis with Malignant Edema and Review of Neurologic Complications from Influenza (2010) (109)
Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States (2015) (104)
Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. (2010) (104)
Ebola Virus Persistence in Semen of Male Survivors. (2016) (101)
Lack of Evidence for Human-to-Human Transmission of Avian Influenza A (H9N2) Viruses in Hong Kong, China 1999 (2002) (99)
The cost of influenza in Thailand. (2006) (98)
Risk factors associated with subclinical human infection with avian influenza A (H5N1) virus--Cambodia, 2006. (2009) (98)
Low Frequency of Poultry-to-Human H5N1 Transmission, Southern Cambodia, 2005 (2006) (97)
Lack of evidence of avian-to-human transmission of avian influenza A (H5N1) virus among poultry workers, Kano, Nigeria, 2006. (2007) (91)
What Obstetrician–Gynecologists Should Know About Ebola: A Perspective From the Centers for Disease Control and Prevention (2014) (91)
Low Pathogenic Avian Influenza A (H7N2) Virus Infection in Immunocompromised Adult, New York, USA, 2003 (2012) (90)
A population-based study of neurologic manifestations of severe influenza A(H1N1)pdm09 in California. (2012) (87)
Ebola virus disease and critical illness (2016) (86)
Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response. (2011) (86)
Increase in Human Infections with Avian Influenza A(H7N9) Virus During the Fifth Epidemic — China, October 2016–February 2017 (2017) (85)
Factors Associated With Prolonged Viral Shedding in Patients With Avian Influenza A(H7N9) Virus Infection (2018) (83)
Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients (2015) (83)
Influenza virus infection among pediatric patients reporting diarrhea and influenza-like illness (2010) (82)
The substantial hospitalization burden of influenza in central China: surveillance for severe, acute respiratory infection, and influenza viruses, 2010–2012 (2013) (81)
Large summertime influenza A outbreak among tourists in Alaska and the Yukon Territory. (2003) (81)
Preliminary Epidemiology of Human Infections with Highly Pathogenic Avian Influenza A(H7N9) Virus, China, 2017 (2017) (81)
Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease. (2015) (79)
The burden of influenza in East and South‐East Asia: a review of the English language literature (2008) (77)
Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick. (2015) (77)
Pandemic H1N1 and the 2009 Hajj (2009) (75)
Seroprevalence of Antibodies to Avian Influenza A (H5) and A (H9) Viruses among Market Poultry Workers, Hanoi, Vietnam, 2001 (2012) (72)
Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1). (2009) (71)
Global epidemiology of human infections with highly pathogenic avian influenza A (H5N1) viruses (2008) (70)
Update: Increase in Human Infections with Novel Asian Lineage Avian Influenza A(H7N9) Viruses During the Fifth Epidemic — China, October 1, 2016–August 7, 2017 (2017) (70)
Highly Pathogenic Avian Influenza A(H7N3) Virus in Poultry Workers, Mexico, 2012 (2013) (69)
Human Influenza A (H5N1) Cases, Urban Areas of People’s Republic of China, 2005–2006 (2007) (67)
Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome (2021) (67)
Neuraminidase Inhibitors for Critically Ill Children With Influenza (2013) (66)
Comparison of Symptoms and RNA Levels in Children and Adults With SARS-CoV-2 Infection in the Community Setting. (2021) (65)
Preparing for influenza after 2009 H1N1: special considerations for pregnant women and newborns. (2011) (65)
Fifty Years of Influenza A(H3N2) Following the Pandemic of 1968. (2020) (65)
Sepsis and the Global Burden of Disease in Children. (2016) (64)
Clinical Characteristics of Patients Hospitalized with Coronavirus Disease, Thailand (2020) (64)
New filovirus disease classification and nomenclature (2019) (63)
Preliminary Epidemiologic Assessment of Human Infections With Highly Pathogenic Avian Influenza A(H5N6) Virus, China (2017) (63)
Values for preventing influenza-related morbidity and vaccine adverse events in children (2005) (60)
Clinical Description of a Completed Outbreak of SARS in Vietnam, February–May, 2003 (2004) (58)
Factors affecting QuickVue Influenza A + B rapid test performance in the community setting. (2009) (58)
Factors associated with nosocomial SARS-CoV transmission among healthcare workers in Hanoi, Vietnam, 2003 (2006) (58)
Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09‐related pneumonia: an individual participant data meta‐analysis (2015) (57)
A national survey of severe influenza-associated complications among children and adults, 2003-2004. (2005) (57)
The Association between Serum Biomarkers and Disease Outcome in Influenza A(H1N1)pdm09 Virus Infection: Results of Two International Observational Cohort Studies (2013) (57)
Evidence of SARS-CoV-2 Replication and Tropism in the Lungs, Airways and Vascular Endothelium of Patients with Fatal COVID-19: An Autopsy Case-Series. (2021) (55)
Readiness for Responding to a Severe Pandemic 100 Years After 1918 (2018) (54)
Systematic Review: Safety and Efficacy of Extended-Duration Antiviral Chemoprophylaxis Against Pandemic and Seasonal Influenza (2009) (52)
Seroprevalence of Antibodies to Avian Influenza Virus A (H5N1) among Residents of Villages with Human Cases, Thailand, 2005 (2009) (51)
Low Frequency of Poultry-to-Human H 5 N 1 Virus Transmission , Southern Cambodia , 2005 (2006) (51)
Timing of Influenza A(H5N1) in Poultry and Humans and Seasonal Influenza Activity Worldwide, 2004–2013 (2015) (50)
CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES‐I statement): an extension of the STROBE statement (2016) (50)
National surveillance for influenza and influenza-like illness in Vietnam, 2006-2010. (2013) (50)
Preventing and controlling influenza with available interventions. (2014) (49)
Post-Ebola Signs and Symptoms in U.S. Survivors. (2015) (49)
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial (2021) (48)
Avian Influenza Virus A (H5N1), Detected through Routine Surveillance, in Child, Bangladesh (2009) (48)
Impact of the Fall 2009 Influenza A(H1N1)pdm09 Pandemic on US Hospitals (2013) (47)
What Is the Optimal Therapy for Patients with H5N1 Influenza? (2009) (47)
Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir (2019) (47)
Assessing Change in Avian Influenza A(H7N9) Virus Infections During the Fourth Epidemic - China, September 2015-August 2016. (2016) (46)
Severe morbidity and mortality associated with influenza in children and young adults--Michigan, 2003. (2003) (45)
Universal influenza vaccination in the United States: are we ready? Report of a meeting. (2006) (45)
Novel influenza A viruses and pandemic threats (2017) (45)
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (2005) (42)
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (2003) (42)
Clusters of Human Infection and Human-to-Human Transmission of Avian Influenza A(H7N9) Virus, 2013–2017 (2018) (42)
Surveillance of Influenza in Indonesia, 2003–2007 (2012) (41)
Field performance and new uses of rapid influenza testing in Thailand. (2007) (40)
Early observational research and registries during the 2009–2010 influenza A pandemic (2010) (39)
Historical and clinical aspects of the 1918 H1N1 pandemic in the United States. (2019) (39)
Incubation Period for Human Cases of Avian Influenza A (H5N1) Infection, China (2008) (37)
Highly Pathogenic Avian Influenza A(H5N1) Virus Infection among Workers at Live Bird Markets, Bangladesh, 2009–2010 (2015) (37)
Peramivir use for treatment of hospitalized patients with influenza A(H1N1)pdm09 under emergency use authorization, October 2009-June 2010. (2012) (37)
Live Animal Markets in Minnesota: A Potential Source for Emergence of Novel Influenza A Viruses and Interspecies Transmission. (2015) (37)
Use of Intravenous Peramivir for Treatment of Severe Influenza A(H1N1)pdm09 (2012) (36)
National influenza surveillance in Vietnam, 2006-2007. (2009) (36)
Characteristics and Outcomes of Influenza-Associated Encephalopathy Cases Among Children and Adults in Japan, 2010–2015 (2017) (36)
Risk factors for mechanical ventilation in U.S. children hospitalized with seasonal influenza and 2009 pandemic influenza A* (2012) (36)
Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey (2018) (36)
Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study: Reverse Transcription-Polymerase Chain Reaction and Cataract Surgery Outcomes of Ebola Survivors in Sierra Leone☆ (2018) (35)
Cross‐sectional survey and surveillance for influenza viruses and MERS‐CoV among Egyptian pilgrims returning from Hajj during 2012‐2015 (2016) (34)
Outcomes of Influenza A(H1N1)pdm09 Virus Infection: Results from Two International Cohort Studies (2014) (34)
Uveitis and Systemic Inflammatory Markers in Convalescent Phase of Ebola Virus Disease (2016) (34)
Ebola virus disease and children: what pediatric health care professionals need to know. (2014) (33)
Diagnostic testing for 2009 pandemic influenza A (H1N1) virus infection in hospitalized patients. (2009) (33)
Increased Number of Human Cases of Influenza Virus A(H5N1) Infection, Egypt, 2014–15 (2015) (31)
Genetic analysis of avian influenza A viruses isolated from domestic waterfowl in live-bird markets of Hanoi, Vietnam, preceding fatal H5N1 human infections in 2004 (2009) (31)
Burden of Influenza in 4 Ecologically Distinct Regions of Peru: Household Active Surveillance of a Community Cohort, 2009-2015. (2017) (31)
Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Isolated from Poultry, Vietnam, 2009–2011 (2013) (31)
Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series (2021) (31)
Who gets hospitalized for influenza pneumonia in Thailand? Implications for vaccine policy. (2007) (30)
Neurologic complications of 2009 influenza A (H1N1) (2010) (30)
Influenza-Associated Intensive-Care Unit Admissions and Deaths — California, September 29, 2013–January 18, 2014 (2014) (29)
Demographic and Clinical Predictors of Mortality from Highly Pathogenic Avian Influenza A (H5N1) Virus Infection: CART Analysis of International Cases (2014) (28)
Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor. (2016) (27)
Population-based active surveillance cohort studies for influenza: lessons from Peru. (2012) (27)
Loperamide therapy for voluminous diarrhea in Ebola virus disease. (2015) (27)
Influenza-Associated Acute Necrotizing Encephalopathy in Siblings. (2018) (27)
Resource-poor settings: infrastructure and capacity building: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. (2014) (27)
Seasonal Patterns in Human A (H5N1) Virus Infection: Analysis of Global Cases (2014) (26)
The effects of the COVID-19 pandemic on community respiratory virus activity (2022) (26)
Seroprevalence of Antibodies against Highly Pathogenic Avian Influenza A (H5N1) Virus among Poultry Workers in Bangladesh, 2009 (2013) (26)
Oseltamivir Treatment of Influenza in Children. (2018) (26)
Predictors at admission of mechanical ventilation and death in an observational cohort of adults hospitalized with COVID-19 (2020) (25)
Clinical experience with intravenous zanamivir under an emergency investigational new drug program in the United States. (2013) (25)
Impact of influenza on young children and the shaping of United States influenza vaccine policy (2003) (25)
Influenza vaccination in children with neurologic or neurodevelopmental disorders. (2015) (25)
Hospital Triage System for Adult Patients Using an Influenza-Like Illness Scoring System during the 2009 Pandemic—Mexico (2010) (25)
100 Years of Medical Countermeasures and Pandemic Influenza Preparedness (2018) (25)
Seroepidemiologic investigation of an outbreak of pandemic influenza A H1N1 2009 aboard a US Navy Vessel—San Diego, 2009 (2013) (24)
Valuing health across the lifespan: health state preferences for seasonal influenza illnesses in patients of different ages. (2011) (24)
Ebola virus disease: an update on post-exposure prophylaxis. (2017) (24)
Novel Avian Influenza A Virus Infections of Humans. (2019) (24)
Rapid influenza diagnostic test use and antiviral prescriptions in outpatient settings pre- and post-2009 H1N1 pandemic. (2014) (24)
2009 H1N1 virus transmission and outbreaks. (2010) (24)
Serum sickness-like reaction associated with inactivated influenza vaccination among Thai health care personnel: risk factors and outcomes. (2009) (24)
Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirus. (2016) (24)
Assessment of Human-to-Human Transmissibility of Avian Influenza A(H7N9) Virus Across 5 Waves by Analyzing Clusters of Case Patients in Mainland China, 2013–2017 (2018) (23)
High-risk Groups for Influenza Complications. (2020) (22)
Antivirals for influenza: a summary of a systematic review and meta‐analysis of observational studies (2013) (22)
Critically ill patients with influenza A(H1N1)pdm09 virus infection in 2014. (2014) (22)
Recombinant Protein-Based Assays for Detection of Antibodies to Severe Acute Respiratory Syndrome Coronavirus Spike and Nucleocapsid Proteins (2007) (22)
What We Are Watching—Top Global Infectious Disease Threats, 2013-2016: An Update from CDC's Global Disease Detection Operations Center (2017) (21)
Cost-effectiveness of oseltamivir treatment for children with uncomplicated seasonal influenza. (2012) (21)
INSIGHT FLU005: An Anti-Influenza Virus Hyperimmune Intravenous Immunoglobulin Pilot Study. (2016) (20)
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study (2021) (20)
Pediatric influenza‐associated myositis – Nebraska, 2001–2007 (2009) (20)
Severe influenza among children and young adults with neurologic and neurodevelopmental conditions - Ohio, 2011. (2012) (19)
Early Identification and Prevention of the Spread of Ebola - United States. (2016) (18)
Long-term clinical prognosis of human infections with avian influenza A(H7N9) viruses in China after hospitalization (2020) (18)
Pandemic influenza and pregnancy revisited: lessons learned from 2009 pandemic influenza A (H1N1). (2011) (18)
Avian Influenza A (H5N1) Virus (2007) (18)
Use of rapid tests and antiviral medications for influenza among primary care providers in the United States (2009) (18)
Microbial signatures in the lower airways of mechanically ventilated COVID19 patients associated with poor clinical outcome (2021) (18)
Characterizing wild bird contact and seropositivity to highly pathogenic avian influenza A (H5N1) virus in Alaskan residents (2014) (17)
Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection (2019) (17)
Middle East Respiratory Syndrome Coronavirus and Children (2017) (17)
Pandemic influenza in Africa, lessons learned from 1968: a systematic review of the literature (2011) (17)
Seroprevalence of Antibodies to Highly Pathogenic Avian Influenza A (H5N1) Virus among Close Contacts Exposed to H5N1 Cases, China, 2005–2008 (2013) (17)
Preliminary population‐based epidemiological and clinical data on 2009 pandemic H1N1 influenza A (pH1N1) from Lima, Peru (2009) (17)
Care of the Child With Ebola Virus Disease* (2015) (17)
Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus (2016) (17)
Influenza Activity in the US During the 2020-2021 Season. (2021) (17)
Influenza (2022) (17)
Healthcare-seeking behaviors for acute respiratory illness in two communities of Java, Indonesia: a cross-sectional survey (2016) (16)
Prevention and control of influenza. (1986) (16)
Human Coronavirus-Associated Influenza-Like Illness in the Community Setting in Peru. (2015) (16)
Original Article: A primary school outbreak of pandemic 2009 influenza A (H1N1) in China (2010) (16)
Clinical Development of Therapeutic Agents for Hospitalized Patients With Influenza: Challenges and Innovations. (2019) (15)
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial. (2022) (15)
Gaps in the Clinical Management of Influenza: A Century Since the 1918 Pandemic. (2018) (14)
Modes of Transmission of Influenza B Virus in Households (2014) (14)
Reduction of Seasonal Influenza Transmission among Healthcare Workers in an Intensive Care Unit: A 4-Year Intervention Study in Thailand (2010) (14)
Trends in COVID-19 vaccination intent and factors associated with deliberation and reluctance among adult homeless shelter residents and staff, 1 November 2020 to 28 February 2021 – King County, Washington (2021) (14)
Public Health Implications of Avian Influenza Viruses (2009) (14)
Ebola virus disease: What clinicians in the United States need to know. (2015) (14)
Prevention and Control of Seasonal Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2009 department of health and human services Centers for Disease Control and Prevention (2009) (14)
Mild Respiratory Illness Among Young Children Caused by Highly Pathogenic Avian Influenza A (H5N1) Virus Infection in Dhaka, Bangladesh, 2011 (2017) (14)
Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015 (2017) (13)
No Evidence of Avian Influenza A H5N1 among Returning US Travelers (2007) (13)
Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015 (2017) (13)
Increase in Outpatient Ivermectin Dispensing in the US During the COVID-19 Pandemic: A Cross-Sectional Analysis (2021) (13)
Preliminary Evaluation of the Effect of Investigational Ebola Virus Disease Treatments on Viral Genome Sequences. (2016) (13)
Unexplained Respiratory Disease Outbreak working group activities - worldwide, March 2007-September 2011. (2012) (13)
Clinical characteristics and factors associated with severe acute respiratory infection and influenza among children in Jingzhou, China (2016) (12)
The East Jakarta Project: surveillance for highly pathogenic avian influenza A(H5N1) and seasonal influenza viruses in patients seeking care for respiratory disease, Jakarta, Indonesia, October 2011–September 2012 (2015) (12)
Engagement and Education (2014) (12)
Evaluation of the point-of-care Becton Dickinson Veritor™ Rapid influenza diagnostic test in Kenya, 2013–2014 (2017) (11)
Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses. (2010) (11)
Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study (2017) (11)
Laboratory-based respiratory virus surveillance pilot project on select cruise ships in Alaska, 2013–15 (2017) (11)
Specificity, kinetics and longevity of antibody responses to avian influenza A(H7N9) virus infection in humans (2020) (11)
A population‐based estimate of the economic burden of influenza in Peru, 2009–2010 (2016) (10)
Detection of SARS-CoV-2 in Neonatal Autopsy Tissues and Placenta (2022) (10)
Bioaerosol Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Referral Center with Critically Ill Coronavirus Disease 2019 (COVID-19) Patients March–May 2020 (2021) (10)
A Step Forward in the Treatment of Influenza. (2018) (10)
Neuraminidase H275Y and hemagglutinin D222G mutations in a fatal case of 2009 pandemic influenza A (H1N1) virus infection (2012) (9)
Remote Household Observation for Noninfluenza Respiratory Viral Illness (2020) (9)
Gastrointestinal bleeding and gastric outlet obstruction from Peutz-Jeghers polyposis. Diagnosis and treatment. (1997) (9)
Bioaerosol sampling for SARS-CoV-2 in a referral center with critically ill COVID-19 patients March-May 2020. (2021) (9)
Successful treatment with hydrochlorothiazide and amiloride in an infant with congenital nephrogenic diabetes insipidus (1993) (8)
Public health implications of animal influenza viruses (2016) (8)
Influence of Molecular Testing on Influenza Diagnosis. (2018) (8)
Evaluation of potential risk of transmission of avian influenza A viruses at live bird markets in response to unusual crow die‐offs in Bangladesh (2020) (7)
Interpretation of Relative Efficacy and Effectiveness for Influenza Vaccines (2021) (7)
Case records of the Massachusetts General Hospital. Case 40-2009. A 29-year-old man with Fever and respiratory failure. (2009) (7)
Children With Special Health Care Needs and Preparedness: Experiences From Seasonal Influenza and the 2009 H1N1 Influenza Pandemic (2012) (7)
New England Medical Journal (2007) (7)
Physician's knowledge, attitudes, and practices regarding seasonal influenza, pandemic influenza, and highly pathogenic avian influenza A (H5N1) virus infections of humans in Indonesia (2016) (7)
Kinetics of Serological Responses in Critically Ill Patients Hospitalized With 2009 Pandemic Influenza A(H1N1) Virus Infection in Canada, 2009–2011 (2018) (6)
Administration of Bamlanivimab to Skilled Nursing Facility Residents During a COVID-19 Outbreak, January-February 2021, Arizona (2021) (6)
Clinical Effectiveness and Safety of Antivirals for Influenza in Pregnancy. (2021) (6)
The Intersection of Care Seeking and Clinical Capacity for Patients With Highly Pathogenic Avian Influenza A (H5N1) Virus in Indonesia: Knowledge and Treatment Practices of the Public and Physicians (2016) (6)
Serological evidence of human infections with highly pathogenic avian influenza A(H5N1) virus: a systematic review and meta-analysis (2020) (6)
COVID-19 Clinical Phenotypes: Presentation and Temporal Progression of Disease in a Cohort of Hospitalized Adults in Georgia, United States (2020) (6)
Effects of Influenza on Pregnant Women and Infants (2013) (6)
Clinical management of critically ill adults with coronavirus disease 2019 (COVID-19) (2020) (5)
First Case of Covid-19 in the United States. Reply. (2020) (5)
Estimated Incubation Period and Serial Interval for Human-to-Human Influenza A(H7N9) Virus Transmission (2019) (5)
Point-of-care molecular testing and antiviral treatment of influenza in residents of homeless shelters in Seattle, WA: study protocol for a stepped-wedge cluster-randomized controlled trial (2020) (5)
The PARADIGM of Influenza Vaccination in Heart Failure Patients. (2016) (5)
Invasive Streptococcus pneumoniae infection among hospitalized patients in Jingzhou city, China, 2010-2012 (2018) (5)
A remote household‐based approach to influenza self‐testing and antiviral treatment (2021) (5)
Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) Prepared by (2005) (4)
Preparing for the 2020-2021 Influenza Season. (2020) (4)
The Special Pathogens Research Network: Enabling Research Readiness. (2019) (4)
Influenza virus infection mimicking an acute abdomen in a female adolescent (2013) (4)
Evaluating Promising Investigational Medical Countermeasures: Recommendations in the Absence of Guidelines. (2019) (4)
Leveraging International Influenza Surveillance Systems and Programs during the COVID-19 Pandemic (2022) (4)
ICU Resource Limitations During Peak Seasonal Influenza: Results of a 2018 National Feasibility Study (2022) (4)
Commentary: A Historical Review of Centers for Disease Control and Prevention Antiviral Treatment and Postexposure Chemoprophylaxis Guidance for Human Infections With Novel Influenza A Viruses Associated With Severe Human Disease (2017) (3)
Seasonal Influenza and Avian Influenza A(H5N1) Virus Surveillance among Inpatients and Outpatients, East Jakarta, Indonesia, 2011–2014 (2019) (3)
Sampling for SARS-CoV-2 Aerosols in Hospital Patient Rooms (2021) (3)
Acute rhabdomyolysis and delayed pericardial effusion in an Italian patient with Ebola virus disease: a case report (2017) (3)
Clinical Management of Ebola Virus Disease Patients (2015) (3)
Influenza surveillance with rapid diagnostic tests. (2002) (3)
Baloxavir for Postexposure Prophylaxis against Influenza in Households. (2020) (3)
Microbial signatures in the lower airways of mechanically ventilated COVID19 patients associated with poor clinical outcome (2021) (3)
Demographic and ecological risk factors for human influenza A virus infections in rural Indonesia (2017) (3)
The clinical and genomic epidemiology of seasonal human coronaviruses in congregate homeless shelter settings: A repeated cross-sectional study (2022) (3)
Caught napping in the time of tropical diseases. (2014) (3)
The Clinical and Genomic Epidemiology of Rhinovirus in Homeless Shelters—King County, Washington (2022) (3)
Reply to Verweij et al. (2020) (2)
Clinical outcomes of monoclonal antibody therapy during a COVID‐19 outbreak in a skilled nursing facility—Arizona, 2021 (2022) (2)
Influenza Vaccine for Patients With High-risk Cardiovascular Disease. (2020) (2)
Implementation of the Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) study: Lessons learned for vision health systems strengthening in Sierra Leone (2021) (2)
Case 40-2009 (2010) (2)
303: NATIONAL, REAL-TIME MONITORING OF HOSPITAL RESPONSE DURING THE 2018-2019 INFLUENZA SEASON (2020) (2)
Serological Evidence of Human Infection With Avian Influenza A(H7N9) Virus: A Systematic Review and Meta-analysis (2020) (2)
Update – Swine-origin triple reassortant influenza A ( H 3 N 2 ) variant viruses in North America 17 August 2012 (2012) (1)
Non-pharmaceutical interventions for influenza prevention in households - Pilot findings of a large cluster randomized controlled trial in Hong Kong (2007) (1)
Pilot findings of a randomized trial of non-pharmaceutical interventions to prevent influenza transmission in households in Hong Kong (2008) (1)
Findings of a cluster randomized controlled trial of face masks and hand hygiene to prevent influenza transmission in households (2009) (1)
Severe Acute Respiratory Infection—Preparedness: Protocol for a Multicenter Prospective Cohort Study of Viral Respiratory Infections (2022) (1)
Technical Appendix 1 (2013) (1)
Angiopoietin-Like4 Is a Novel Marker of COVID-19 Severity (2022) (1)
Perceived Hospital Stress, Severe Acute Respiratory Syndrome Coronavirus 2 Activity, and Care Process Temporal Variance During the COVID-19 Pandemic* (2023) (1)
Role Of Bacterial Co-Infection On Illness Severity And Outcomes In ICU Patients With 2009 Pandemic Influenza A (H1N1) Infection (2011) (1)
A randomized trial of face masks and hand hygiene to prevent influenza transmission in households (2008) (1)
Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients (2022) (1)
Influenza (2021) (1)
Seroepidemiology of SARS-CoV-2, Yamagata, Japan, June 2020 (2021) (1)
621: DATA COLLECTION DURING PUBLIC HEALTH EMERGENCIES: LESSONS LEARNED OVER THREE INFLUENZA SEASONS (2020) (1)
Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2008 department of health and human services Centers for Disease Control and Prevention (2008) (1)
UT2 ELICITING TIME TRADE-OFF AMOUNTS FOR HEALTH STATES IN HYPOTHETICAL INDIVIDUALS OF DIFFERENT AGES USING A DISCRETE CHOICE EXPERIMENT (2009) (1)
Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study (2022) (1)
Human Parainfluenza Virus in Homeless Shelters before and during the COVID-19 Pandemic, Washington, USA (2022) (1)
Quality of Life Among Survivors of Middle East Respiratory Syndrome Corona Virus (2016) (1)
Low quality antibody responses in critically ill patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection (2022) (0)
Care of Children with Ebola Virus Disease in Resource-Endowed Settings (2015) (0)
The epidemiology and population-based incidence of influenza in two communities, Bandung District, West Java, Indonesia, 2008-2011 (2019) (0)
Neuraminidase Inhibitors for Critically Ill Children (2013) (0)
Probable vertical transmission of Alpha variant of concern (B.1.1.7) with evidence of SARS-CoV-2 infection in the syncytiotrophoblast, a case report (2023) (0)
Evaluation of a rapid test (QuickVue) by comparing with viral culture for detection of influenza in a sub-tropical community setting (2007) (0)
Pride Options VIII Cape Town 08092013 (2013) (0)
Response to Al-Husayni and Hassoun. (2014) (0)
Phylogenomics of SARS-CoV-2 in Emergency Shelters for People Experiencing Homelessness (2022) (0)
Effects of antiviral son severity and duration of symptoms, viral shedding, and household transmission of influenza (2008) (0)
1359. Human Parainfluenza Epidemiology in Homeless Shelters — King County, Washington (2022) (0)
H5N1 Influenza Virus: Clinical and Epidemiological Features (2006) (0)
Pris au dépourvu par l’arrivée de maladies tropicales (2014) (0)
H5N1 World-wide Epidemiology and Clinical Manifestations (2007) (0)
The trajectories of viral shedding, clinical course and tympanic temperature in natural influenza infections (2009) (0)
Systematic Review: Safety and Efﬁcacy of Extended-Duration Antiviral Chemoprophylaxis Against Pandemic and Seasonal Inﬂuenza (2009) (0)
Late Breaker Oral Abstracts: Influenza and Vaccines (2018) (0)
Use of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Tests by US Infectious Disease Physicians: Results of an Emerging Infections Network Survey, March 2022. (2023) (0)
Perspective The NEW ENGL AND JOURN A L of MEDICI NE (2014) (0)
Pilot findings of a cluster randomized trial of non-pharmaceutical interventions for influenza prevention in households in Hong Kong (2008) (0)
COMMENT The PARADIGM of In fl uenza Vaccination in Heart Failure Patients * (0)
SARS-CoV-2 Screening Testing in Schools: A Comparison of School- Vs. Home-Based Collection Methods (2022) (0)
PIN18 THE IMPACT OF PEDIATRIC ADVERSE EVENTS ON THE COST-EFFECTIVENESS OF OSELTAMIVIR (2008) (0)
RI4 AN ECONOMIC ANALYSIS OF RAPID TESTS AND ANTIVIRAL TREATMENTS FOR INFLUENZA IN CHILDREN (2004) (0)
Erratum to: Clinical Management of Ebola Virus Disease Patients (2015) (0)
New filovirus disease classification and nomenclature (2019) (0)
Effects of oseltamivir on severity and duration of symptoms, viral shedding, and infectivity of influenza (abstract) (2008) (0)
Could treatment with immunomodulatory agents targeting IL-1, IL-6, or JAK signalling improve outcomes in patients with severe influenza pneumonia? A systematic and narrative review (2022) (0)
Oseltamivir provides up to 3 days earlier time to recovery over usual care. (2020) (0)
Results from a test‐and‐treat study for influenza among residents of homeless shelters in King County, WA: A stepped‐wedge cluster‐randomized trial (2023) (0)
Response to Apewokin and Onyishi. (2020) (0)
Low quality antibody responses in critically ill patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection (2022) (0)
Prevention and Control of Seasonal Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2009 Prepared by (2009) (0)
Emergency Management of Infectious Diseases: Influenza (2008) (0)
2202. Influenza Surveillance of Families in an Observational Household Study 2019-2021 (2022) (0)
Effects of oseltamivir treatment on duration of symptoms and viral shedding, and household transmission of influenza virus (2009) (0)
Influenza-associated Neurologic Disease in Children: Greater Efforts are Needed to Prevent and Reduce These Severe Complications. (2022) (0)
The CDC's recommendations for preventing and controlling influenza (2002) (0)
Imported Tickborne Relapsing Fever, France (2005) (0)
Morbidity and Mortality Weekly Report (2003) (0)
The relation between viral shedding and clinical course in natural influenza infections (2009) (0)
1904. Health Behavioral Trends and Absenteeism Associated with Acute Respiratory Illness Before and During the SARS-CoV-2 Pandemic in a Community Household Cohort, King County, Washington (2022) (0)
Faculty Opinions recommendation of Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. (2006) (0)
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19 (2022) (0)
Additional file 1: of Ebola virus disease and critical illness (2016) (0)
Avian Influenza Symposium, November 3, 2004 : transcript (2004) (0)
Evaluation of the quickvue rapid diagnostic test for influenza in a community setting (2007) (0)
Plasma Proteomic Analysis and Targeted Immunoassay Validation Identifies the Role of Endothelial Dysfunction in Development of ARDS, Thrombosis and Clinical Outcomes in Critically Ill COVID-19 Patients (2022) (0)
Evaluation of the QuickVue influenza A+B rapid diagnostic test in a community setting (2008) (0)
Validation of the quickvue rapid diagnostic test for influenza in Hong Kong community (2007) (0)
A Review of Clinical Intervention Trials for Treatment of Patients with Ebola Virus Disease (2016) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Timothy M. Uyeki?

Timothy M. Uyeki is affiliated with the following schools:

Timothy M. Uyeki's Academic­Influence.com Rankings

Timothy M. Uyeki's Degrees

Why Is Timothy M. Uyeki Influential?

Timothy M. Uyeki's Published Works

Published Works

What Schools Are Affiliated With Timothy M. Uyeki?

Timothy M. Uyeki's AcademicInfluence.com Rankings